Eli Lilly and Novo Nordisk to discount weight-loss drugs
The two incretin makers are moving to cut prices on their obesity medicines, according to the report.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 17 03:05 ETSource: Meteo.gr
The wire
- 01The report says Eli Lilly and Novo Nordisk will discount their weight-loss drugs.
- 02Pricing moves by the two dominant incretin manufacturers shape cash-pay costs for patients and the economics of telehealth and compounding channels.
- 03No discount amounts, products or start dates are given in the report; details would need confirmation from the companies.
From the source
Read at meteo.greli lilly and novo nordisk will discount their weight-loss drugs
